Innovation
4 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 592 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |
Developer of therapies for treating cancer and inflammatory diseases
4 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 592 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |